Convalesce Inc
Regenerating neurons, restoring lives
Founded 2018 · $250K raised
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- convalesce.co
- Total Funding
- $250K
- Last Round
- $250K SeedJul 2018
- Rounds
- 1
About
Convalesce is developing a stem cell-based therapy for neurological conditions like Parkinson's disease. Their core innovation is AmGel, a brain-mimetic hydrogel matrix that improves stem cell survival by 300% post-transplantation and confines cells to the target area. The gel's nanoscale topography mimics the brain's extracellular matrix, guiding stem cell differentiation into target neuron types.
Summary
Convalesce Inc is a Biotech company, founded in 2018. It has raised $250K in total across 1 round, most recently a $250K Seed round in Jul 2018. Investors include SOSV and IndieBio.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2018
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...